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Abstract
Background: Stroke-associated pneumonia (SAP) is common in patients with acute ischemic stroke, and several risk
factors have been reported. However, the relationship between underlying leukoaraiosis (LA) and SAP has not been
addressed.
Methods: We collected consecutive patients with acute ischemic stroke within 24 h of symptom onset. SAP was
defined as the lower respiratory tract infection within the first 7 days after stroke onset, according to the modified
Centers for Disease Control and Prevention criteria. LA was graded using the Fazekas scale in both the
periventricular and subcortical areas. We evaluated LA burden by summing the grade and dichotomized into mild
LA (0–2) or severe LA (3–6). Relationship between LA and SAP was analyzed by binary logistic regression analysis
with variables of P < 0.05 in univariate analysis.
Results: Three hundred eight consecutive patients were enrolled, and SAP developed in 44 patients (14%).
Univariate analysis revealed that SAP correlated with age, initial NIHSS score, atrial fibrillation, impaired
consciousness, dysphagia, severe LA and hyperlipidemia. On multivariate analysis, severe LA [adjusted OR (aOR) = 4.
41, 95% CI = 2.04–9.55, P < 0.001 remained independent predictors of SAP after adjusted confounders.
Conclusions: In this study, LA was an independent predictor of SAP. This observation needs to be confirmed in
suitably-designed, prospective studies.
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Background
Pneumonia is a common and significant complication in
patients with acute ischemic stroke. The incidence of
pneumonia in patients with acute ischemic stroke ranges
from 5 to 26% [1, 2]. Stroke-associated pneumonia
(SAP) is correlated with poor functional outcome, pro-
longed hospitalization and high mortality (up to 6-fold)
[2, 3]. Thus, rapid assessment of high-risk patients is
thought to be needed. Known predictors of SAP include
dysphagia, age, male sex, initial stroke severity, non-
lacunar stroke type, diabetes, consciousness, atrial fibril-
lation and acid-suppressive drugs [1, 2, 4, 5].
Leukoaraiosis (LA) is a hyperintense lesion seen in the
cerebral white matter of T2-weighted magnetic resonance
imaging (MRI) [6], which pathologically correlate with
myelin pallor, tissue rarefaction associated with loss of
myelin axons, and mild gliosis [7]. LA is frequently found
in elderly people, but is especially common and wide-
spread in patients with known vascular risk factors and
symptomatic cerebrovascular disease. LA might be im-
portant in swallowing and the disruption of cortical-
subcortical white matter connections plays an important
role in the pathogenesis of dysphagia after stroke [8].
SAP is considered to be the result from the combin-
ation of ongoing aspiration and immunological alter-
ation form stroke-induced immunodepression [9, 10].
Thus, the main aim of present study was to investi-
gate that whether larger burden of LA has a positive
correlation with SAP in acute ischemic stroke.
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We retrospectively collected a consecutive series of
patients with acute ischemic stroke who visited our
stroke center between Jan 2011 and Mar 2013 (n = 1120).
Patients were excluded when they met the following
criteria: a delay of >24 h from symptom onset to visiting
our center (n = 793); age under 18 years (n = 8); and pa-
tients without brain magnetic resonance imaging (MRI)
(n = 11). Finally, a total of 308 patients remained for
secondary analyses (Fig. 1).
Clinical assessment
We assessed the following baseline demographic informa-
tion and risk factors of stroke in all participants: age, sex,
hypertension, diabetes, hyperlipidemia [11], atrial fibrillation,
and smoking. We also collected initial clinical factors includ-
ing stroke subtype, stroke location, stroke severity, presence
of dysphagia, level of consciousness, and use of thrombolysis
therapy. Stroke severity was evaluated using the National
Institute of Health Stroke Scale (NIHSS) score on admission
and discharge date by trained neurologists. Dysphagia was
assessed using a bedside non-instrumented diagnostic test
consisting of 3 sequentially performed subtests (semisolid,
liquid, and solid textures) [12]. Level of consciousness was
dichotomized into normal (NIHSS 1a = 0) and impaired
(NIHSS 1a = 1–3). Mechanisms of stroke were classified
according to the Trial of Org 10172 in Acute Stroke Treat-
ment classification. The location of the stroke lesions was
categorized as either supratentorial or infratentorial. We
also collected the information about clinical outcomes
including hospitalization duration, discharge NIHSS
score, presence of in-hospital mortality, and event of
intubation. Patients underwent routine laboratory exam-
ination within 24 h from admission including white blood
cell count and high sensitivity C-reactive protein levels.
Radiological evaluation
All participants underwent brain MRI and magnetic
resonance angiography within 24 h of the visit with a
3.0-Tesla MR scanner (Achieva 3.0; Philips, Eindoho-
venm, the Netherlands). The MRI protocol included dif-
fusion-weighted images (DWI) [repetition time (TR)/
echo time (TE) = 3000/44 ms], T1-weighted images
[TR/TE = 300/10 ms], T2-weighted images [TR/TE =
3000/100 ms], fluid attenuated inversion recovery im-
ages [TR/TE = 11,000/120 ms], T2 fast field echo im-
ages [TR/TE = 530/16 ms] and three-dimensional time
of flight (TOF) MRA images [TR/TE = 24/3.5 ms]. The
field of view data in all MRI sequences were 240 ×
240 mm. The slice thickness was equally 5.0 mm,
excepting 3.0 mm in DWI and 1.2 mm in TOF images.
We assessed the severity of the LA using the Fazekas scale
in both the periventricular (0–3) and subcortical areas (0–
3) [13]. We then summed the grade from the Fazekas scale
in both areas and dichotomized this grade into mild LA
(sum of grade, 0–2) and severe LA (sum of grade, 3–6)
[14]. Two trained neurologists (K.W.N. and J.S.L.) without
clinical information graded the severity of LA and the
inter-rater reliability coefficient was 0.93. Disagreements
were resolved by discussion with a third reviewer (H.M.K.).
We also evaluated for the presence of lacunar infarcts and
cerebral microbleeds (CMBs). CMBs were divided into
lobar CMBs and deep or infratentorial CMBs according to
the location of the lesion [15].
Definition of pneumonia
A patient was diagnosed as SAP if the lower respiratory
tract infection, which met the modified Centers for Dis-
ease Control (CDC) and Prevention criteria, occurred
within the first 7 days after stroke onset (Additional file 1)
[16]. The evaluation of presence of SAP was conducted
retrospectively by the neurologists (K.W.N. and H.M.K.),
Fig. 1 Patient selection flow of the current study
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who were blinded to other clinical and radiological factors.
Additionally, the chest x-ray was evaluated by one of the
study neurologist (K.W.N.) and a specialized radiologist
(S.W.P.), with an acceptable inter-rater reliability (kappa
coefficient, P = 0.915). We did not categorize the burden
of chest x-ray finding into probable and definite SAP,
considering the retrospective study design. During the
initial three to four days, we observed all participants
closely in our specialized stroke unit. After they were
transferred to the general ward, we continued to
check for the occurrence of SAP.
Statistical analysis
All continuous variables were tested for normal distribu-
tion, and skewed variables were transformed to log-scale
for further statistical analyses. Continuous variables with
normal distribution were presented as the mean ± SD,
while nonparametric ones were presented using the me-
dian value and interquartile range [IQR]. In univariate
analyses, we used Student’s t-test for normally distrib-
uted variables and the Mann-Whitney U-test for non-
parametric variables. For categorical values, we used the
chi-square test and Fisher’s exact test. In multivariate
analyses, we used binary logistic regression to evaluate
independent predictors of SAP. Based on the result from
the univariate analyses, variables of P < 0.05 were se-
lected for the multivariate analysis. We combined prog-
nostic variables of age, atrial fibrillation, dysphagia, male
sex, and initial stroke severity into the A2DS2 score to
avoid overfitting, considering the small number of SAP
events (Additional file 2). The A2DS2 score was dichoto-
mized into low A2DS2 score (0–4) and high A2DS2
score (5–10) [17]. Level of consciousness was excluded
due to close correlation with stroke severity (Pearson
correlation coefficient, P < 0.001). All statistical analyses
were conducted using SPSS 20 (IBM SPSS, Chicago, IL,
USA). A value of P < 0.05 was considered significant.
Results
We collected a total of 308 patients (mean age =
66 years, the median initial NIHSS score = 4 [2–7]).
The mean onset-to-visit time was 6.4 h. SAP occurred
in 44 patients (14%).
Baseline characteristics between patients with and
without SAP are described in Table 1. In the SAP group,
age and the initial NIHSS score were higher compared
with the non-SAP group. In addition, atrial fibrillation,
impaired consciousness, dysphagia and severe LA were
more frequent in the SAP group, while hyperlipidemia
was less. The median A2DS2 score was 2 and high A2DS2
score was more frequent in the SAP group.
According to multivariate analyses, severe LA [ad-
justed OR (aOR) = 4.41, 95% CI = 2.04–9.55, P < 0.001],
hyperlipidemia (aOR = 0.40, 95% CI = 0.17–0.97, P = 0.043),
and high A2 DS2 score (aOR = 6.71, 95% CI = 3.10–
14.52, P < 0.001) remained independent predictors of
SAP (Table 2).
We further analyzed characteristics according to the
severity of LA in using subgroup analysis. Older age,
Table 1 Baseline characteristics between with and without
stroke associated pneumonia
Non-SAP (n = 264) SAP (n = 44) P value
Age, y 65 [56–74] 71 [66–79] <0.001
Sex, male (%) 161 (61) 31 (70) 0.230
Hypertension (%) 185 (70) 34 (77) 0.330
Diabetes (%) 83 (31) 17 (39) 0.345
Hyperlipidemia (%) 110 (42) 10 (23) 0.017
Atrial fibrillation (%) 40 (15) 18 (41) <0.001
Smoking (%) 132 (50) 22 (50) 1.000
Initial total NIHSS [IQR] 3 [1–6] 11 [4–19] <0.001
Level of consciousness (%) <0.001
Normal (NIHSS 1a = 0) 251 (95) 28 (64)
Impaired (NIHSS 1a = 1–3) 13 (5) 16 (36)
A2DS2 score <0.001
Low (0–4) 219 (85) 18 (43)
High (5–10) 38 (15) 24 (57)
Thrombolysis (%) 0.626
None 237 (90) 39 (89)
Intravenous 23 (9) 4 (9)
Intra-arterial 2 (1) 0 (0)
Both 2 (1) 1 (2)
Dysphagia (%) 34 (13) 24 (56) <0.001
Stroke subtype (%) 0.056
Large artery disease 93 (35) 18 (41)
Cardioembolism 51 (19) 18 (41)
Small vessel occlusion 92 (35) 3 (7)
Undetermined 28 (11) 5 (11)
Stroke location (%) 0.466
Supratentorial 203 (77) 33 (75)
Infratentorial 54 (20) 8 (18)
Both 7 (3) 3 (7)
Lacunar infarcts (%) 73 (30) 10 (28) 0.804
Lobar cerebral
microbleeds (%)
42 (17) 6 (17) 0.968
Deep/infratentorial
cerebral microbleeds (%)
59 (24) 11 (30) 0.426
Leukoaraiosis (%) <0.001
Mild (0–2) 190 (75) 15 (38)
Severe (3–6) 62 (25) 24 (62)
White blood cell, ×103/μl 7.26 [6.09–9.01] 7.82 [6.67–8.99] 0.149
hs-CRP, mg/dL [IQR] 0.11 [0.05–0.25] 0.15 [0.05–1.36] 0.126
SAP stroke-associated pneumonia, NIHSS National Institute of Health
Stroke Scale, hs-CRP high-sensitivity C-reactive protein
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female sex, and impaired consciousness were correlated
with severe LA (Table 3). In the analysis of discharge
outcomes between two groups, patients in the SAP
group showed longer hospitalization duration, severer
discharge NIHSS score, more frequent in-hospital
mortality and intubation events (Table 4).
Discussion
In this study, SAP occurred in 14% of patients with
acute ischemic stroke, which is similar to what has been
reported in previous studies [1, 2, 17]. We also found
that severe LA was independently associated with SAP
in patients with acute ischemic stroke.
We graded LA in both the periventricular and subcor-
tical areas, as the pathology is different between the two
regions [18]. Our subgroup analysis according to the
locations of the LA consistently revealed severe LA,
which defined as 2 or more Fazekas score in each area,
as a potent predictor of SAP in both the periventricular
(aOR = 4.18, 95% CI = 1.94–8.99, P < 0.001) and subcor-
tical areas (aOR = 3.59, 95% CI = 1.67–7.70, P = 0.001).
Thus, the severity or burden of LA appeared to be more
important rather than the location in SAP.
The association between SAP and LA may be explained
by several hypotheses: First, dysphagia, which is common
in patients with acute stroke (up to 67%) [5], could lead to
aspiration and subsequently SAP. Patients with LA are
known to be more prone to developing dysphagia accord-
ing to its severity [19]. It could be caused by a disruption
in the connection of white matter and reduced input to
the brainstem swallowing center, leading to pseudobulbar
palsy [20]. Additionally, LA has been shown to be an inde-
pendent predictor of dysphagia after acute stroke [8].
Second, it is possible that LA reduces the cough reflex.
Decreased dopamine production by massive structural
disruption of the LA leads to reduce expression of sub-
stance P in the glossopharyngeal nerve and the cervical
parasympathetic ganglion, inhibiting the initiation of the
cough reflex from pharyngeal, laryngeal and tracheal epi-
thelia, which may lead to aspiration [21]. Third, impaired
cognition or consciousness caused by severe LA also
increases the chance for aspiration and could have a role
in SAP. In this study, we found that patients with severe
LA more frequently exhibited impaired consciousness.
The strengths of our study were as following: First, it
is the first study about association between SAP and LA
as a radiological predictor. Second, we also confirmed
that SAP is correlated with poor outcomes in the aspects
of hospitalization duration, neurological function and
mortality, continued to previous study [2, 3]. We also
have several limitations. First, it was a single-center
study with a lower statistical power. We are also cau-
tious in generalizing the results because treatment mo-
dalities or preventive strategies for pneumonia may be
different among centers. Second, we did not measure
the size of the infarct, which may be important for SAP,
as has been shown in other studies [2, 17, 22]. Instead,
we adjusted for the NIHSS score, which is known to be
well correlated with the size of the infarct. Thus, we
believe that not measuring infarct size may not affect
the major outcomes of this study. Third, the effects of
pre-stroke functional status (e.g. modified Rankin score,
cognitive status) should be considered. Fourth, we did
not separate probable and definite SAP according to
radiological findings. Thus, SAP group may have pos-
sibility of heterogeneous traits with different burden
Table 2 Multivariable analysis of possible predictors of stroke associated pneumonia
Crude OR P value Adjusted OR P value
Hyperlipidemia 0.41 [0.20–0.87] 0.020 0.40 [0.17–0.97] 0.043
High A2DS2 score (5–10) 7.68 [3.81–15.50] <0.001 6.71 [3.10–14.52] <0.001
Severe leukoaraiosis 4.90 [2.42–9.93] <0.001 4.41 [2.04–9.55] <0.001
We used binary logistic regression adjusted for hyperlipidemia, A2DS2 score, and severe leukoaraiosis







SAP (%) 15 (7) 24 (28) <0.001
Age, y 62 ± 13 74 ± 10 <0.001
Sex, male (%) 138 (67) 47 (55) 0.040
Hyperlipidemia (%) 85 (41) 31 (36) 0.389
Atrial fibrillation (%) 35 (17) 18 (21) 0.437
Initial NIHSS [IQR] 6 [1–6] 6 [2–7] 0.219
Impaired consciousness (%) 13 (6) 12 (14) 0.034
Dysphagia (%) 31 (16) 22 (26) 0.062
SAP stroke-associated pneumonia, LA leukoaraiosis, NIHSS National Institute of
Health Stroke Scale






Hospitalization duration, d [IQR] 9 [7–14] 30 [14–51] <0.001
Discharge NIHSS score [IQR] 2 [0–4] 9 [5–18] <0.001
In-hospital mortality, % 0 (0) 3 (7) 0.003
Event of intubation, % 1 (0) 7 (16) <0.001
SAP stroke-associated pneumonia, NIHSS National Institute of Health
Stroke Scale
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of SAP. Last, the type of pneumonia and its nature (e.g.
aspiration pneumonia, microaspiration pneumonia) should
be confounded.
Conclusions
In conclusion, severe LA may predict SAP in patients
with acute ischemic stroke. In clinical practice, careful
observation of these high risk patients can be helpful to
find SAP. Although these findings may be interpreted as
potential hypothesis generation, further validation by
larger prospective studies may be needed.
Additional files
Additional file 1: Diagnostic criteria for stroke associated pneumonia
based on the CDC criteria. (DOCX 25 kb)
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